JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 26, 2003
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
278/52/52223    most recent
M308779200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, E. R.
Right arrow Articles by Morgan, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, E. R.
Right arrow Articles by Morgan, I. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print October 14, 2003
J. Biol. Chem, 10.1074/jbc.M308779200
Submitted on August 8, 2003
Revised on October 6, 2003
Accepted on October 14, 2003

The fidelity of HPV16 E1/E2 mediated DNA replication

Ewan R. Taylor, Edward S. Dornan, Winifred Bonar, Julie A. Connolly, Shona McNair, Patricia Kannouche, Alan R. Lehmann, and Iain M. Morgan

Veterinary Pathology, University of Glasgow, Glasgow G61 1QH

Corresponding Author: i.morgan{at}vet.gla.ac.uk

Human papillomaviruses (HPV) are causative agents in a variety of human diseases; for example over 99% of cervical carcinomas contain HPV DNA sequences. Often in cervical carcinoma the HPV genome is integrated into the host genome resulting in unregulated expression of the viral transforming proteins E6 and E7. Therefore viral integration is a step towards HPV induced carcinogenesis. Integration of the HPV genome could occur following double-strand DNA breaks that could arise during viral DNA replication. We investigated the fidelity of HPV 16 E1 and E2 mediated DNA replication of non-damaged and UVC damaged templates in a variety of cell lines with different genetic backgrounds; C33a (derived from an HPV negative cervical carcinoma), XP30RO (deficient in the by-pass polymerase h), XP30h (expressing a restored wild type polh), XP12RO (nucleotide excision repair defective) and MRC5 (derived from a 14 week old human foetus). The results demonstrate that the fidelity of E1 and E2 mediated DNA replication is reflective of the genetic background in which the assays are carried out. For example, restoring polh to the XP30 cell line results in a three-fold drop in the number of mutants obtained following replication of a UVC damaged template. A relatively high percentage of the mutant replicated molecules arise as a result of genetic rearrangement. This is the first time such studies have been carried out with an HPV replication system and the results are discussed in the context of the HPV life cycle and what is known about HPV genomes in human cancers.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.